Login

David Gandler, CEO of Fubo TV, discusses the impact of the merger between competitors DISH and DirecTV on 'Closing Bell'. 00:10:00

Share On Facebook Share On Twitter

David Gandler is Co-founder and CEO of FuboTV Inc.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
The Magic of Thinking Big: Reaching EdTech’s Massive Market Cap Potential | Chip Paucek, CEO , 2U Inc.
00:10:00
Global Geosciences CEO Discusses Low-Cost Lithium-Boron Production at Rhyolite Ridge
00:10:00
Nasdaq Interview Harness The Power of AI with Chad Steelberg | Chad Steelberg, CEO, Veritone IncVERI:NMQ
00:10:00
Neolithium CEO Waldo Perez Discusses Expansion of Lithium Resource and Strategic Partnerships
00:10:00
Alexandre Guerrero on Eletromidia's Growth, Globo Partnership, and Future Prospects | Alexandre Guerrero , CEO , Eletromidia SA.
00:10:00
Investing in Latina(o)-owned early-stage companies with high growth performancel|Kennie Blanco,General Partner and Chief Investment Officer,L'ATTITUDE Ventures
00:10:00
Is Albemarle Corp. Set to Bounce Back in the Lithium Market?
00:10:00
Artemis Gold's Blackwater Mine on Track with 45% Construction Complete, Focused on Expansion and Sustainability
00:10:00
Los Cerros Advances Drilling with Promising Results at Tesorito and Andes Projects in Colombia
00:10:00
Sanko Gold: Driving Growth and Cash Flow from Ghana's Assanko Mine
00:10:00
A Leading Global Asset Manager Specializing in the Public & Private Credit Markets|Bruce Richards,CEO, Chairman, & Founder,Marathon
00:10:00
Shifting business priorities increase the rate and complexity of change needed in every company | Meryl Rosenthal,CEO, Co-Founder, and Board Chair, flexPATH Index Moderate 2065 Fund Fee

© 2017 - Neuhu+